E. Celis

发表

Lan, A. Sette, E. Appella, 1999 .

Identification of GP100‐derived, melanoma‐specific cytotoxic T‐lymphocyte epitopes restricted by HLA‐A3 supertype molecules by primary in vitro immunization with peptide‐pulsed dendritic cells

A. Sette, V. Tsai, K. Takesako, 1998, International journal of cancer.

Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2.

S. Ferrone, X. Wang, T. Kageshita, 2003, Tissue antigens.

Vaccines for the Induction of Antitumor Multiepitope Trojan Antigen Peptide

E. Appella, Y. Higashimoto, Jun Lu, 2004 .

Identification of HLA‐A24 epitope peptides of carcinoembryonic antigen which induce tumor‐reactive cytotoxic T lymphocyte

A. Sette, I. Kato, K. Takesako, 1999, International journal of cancer.

Identification of HLA‐A24 epitope peptides of carcinoembryonic antigen which induce tumor‐reactive cytotoxic T lymphocyte

A. Sette, I. Kato, E. Celis, 1999, International journal of cancer.

Identification of New Epitopes from Four Different Tumor-Associated Antigens: Recognition of Naturally Processed Epitopes Correlates with HLA-A∗0201-Binding Affinity1

Alessandro Sette, Scott Southwood, A. Sette, 2001, The Journal of Immunology.

TAP-Independent Presentation of CTL Epitopes by Trojan Antigens1

E. Appella, Y. Higashimoto, P. Wettstein, 2001, The Journal of Immunology.

Study of HLA system in a Mataco population: a geographically isolated American Indian tribe.

C. Vullo, C. Riera, H. Serra, 2008, Tissue antigens.

Fine restriction analysis and inhibition of antigen recognition in HLA‐DQ‐restricted T cells by major histocompatibility complex blockers and T cell receptor antagonists

A. Sette, C. Crimi, H. Serra, 1993, European journal of immunology.

Therapeutic Vaccination in Humans Infection and its Role in Response to Associated with Chronic Hepatitis B Virus Altered Helper T Lymphocyte Function

A. Sette, F. Chisari, R. Chesnut, 1999 .

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells

J. Thompson, D. Byrd, S. Riddell, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans.

A. Sette, F. Chisari, R. Chesnut, 1999, Journal of immunology.

Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.

F. Marincola, E. Trimble, A. Sette, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete Freund's adjuvant in patients with resected high-risk melanoma.

E. Celis, J. Weber, V. Marty, 1999, Journal of immunotherapy.

Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope.

A. Sette, G. Fleuren, C. Melief, 1996, Cancer research.

Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules

J. Berzofsky, C. Rice, A. Sette, 1995, Journal of virology.

Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis.

A. Sette, J. Flynn, B. Bloom, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.

H. Grey, A. Sette, R. Chesnut, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells.

J. Sidney, A. Sette, K. Sakaguchi, 1997, Journal of immunology.

HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients.

A. Sette, E. Celis, R. Shapiro, 1998, Journal of immunology.

Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen.

E. Celis, Jun Lu, H Kobayashi, 2001, Cancer research.

Genetic restriction and fine specificity of human T cell clones reactive with rabies virus.

R. Karr, E. Celis, H. Koprowski, 1988, Journal of immunology.

Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules.

M F del Guercio, R W Chesnut, A Sette, 1996, Human immunology.

Specific T cell recognition of peptides derived from prostate-specific antigen in patients with prostate cancer.

V. Tsai, R. Alexander, E. Celis, 1998, Urology.

Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.

C Crimi, R W Chesnut, A Sette, 1996, International immunology.

Recognition of rabies and rabies-related viruses by T cells derived from human vaccine recipients

E. Celis, H. Koprowski, B. Dietzschold, 1988, Journal of virology.

Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas.

A Sette, O. Larsson, A. Sette, 1999, Journal of immunology.

Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides.

L. Otvos, E. Celis, D. Ou, 1988, Journal of immunology.

Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells.

A. Sette, E. Appella, R. Kiessling, 1997, Cancer research.

Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules.

M F del Guercio, R W Chesnut, A Sette, 1995, Journal of immunology.

This information is current as Carcinomas and Melanomas CTL Against Autologous and Allogeneic Peptide Epitopes That Can Elicit Specific Identification of New HER2/neu-Derived

J. Charo, C. Hising, M. Petersson, 2013 .